Richard Thomas Hale, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 West Oak St, Frackville, PA 17931 Phone: 570-874-4100 |
Dr. James P. Langon, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 W Oak St, Frackville, PA 17931 Phone: 570-874-4100 Fax: 570-874-4182 |
James C Greenfield, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 40 W Frack St, Frackville, PA 17931 Phone: 570-794-6123 Fax: 570-794-6124 |
Dr. Casey D. Nowak, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 W Oak St, Frackville, PA 17931 Phone: 570-874-4100 Fax: 570-874-4182 |
Dr. Thomas R. Graf, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 701 W Oak St, Frackville, PA 17931 Phone: 570-874-4100 Fax: 570-874-4182 |
Anne Patricia Cadau, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 W Oak St, Frackville, PA 17931 Phone: 570-874-4100 Fax: 570-874-4182 |
Dr. Darrin Eric Doran, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 10 E Spruce St, Frackville, PA 17931 Phone: 570-874-7001 |
Dr. Ivor F. Lewis, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 W Oak St, Frackville, PA 17931 Phone: 570-874-4100 Fax: 570-874-4182 |
Dr. Walter W Setlock, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 E Spruce St, Frackville, PA 17931 Phone: 570-874-7001 Fax: 570-874-2598 |
News Archive
A new study by University of Kentucky Markey Cancer Center researchers suggests that targeting a key enzyme and its associated metabolic programming may lead to novel drug development to treat lung cancer.
Researchers are kick-starting better diabetic foot care and promoting reduced radiation dose with a new take on a hybrid molecular imaging technique. By targeting both bone cell activity and immune response and improving imaging data interpretation, doctors can better distinguish diabetic foot infection from another common foot condition that often requires an additional bone-marrow scan for definitive diagnosis, say researchers presenting a study at the Society of Nuclear Medicine and Molecular Imaging's 2013 Annual Meeting.
Cellular Dynamics International (CDI) and Promega have entered into a research collaboration with the goal of bringing more relevant and highly predictive toxicity testing to the drug discovery process. Pharmaceutical discovery scientists will now be able to combine bioassays with human cardiomyocytes to improve prediction of unintentional, detrimental side effects that have previously remained undetected until late in the development process or after release of the drug to the general public.
Certain men age 75 to 80 are unlikely to benefit from routine prostate specific antigen (PSA) testing, according to a Johns Hopkins study published in the April 2009 issue of The Journal of Urology.
› Verified 5 days ago